Share

Latest Research, Industry, Medical and Scientific News

Atlanta-based Founder Seeks to Help Give Control for Incontinence

Urinary incontinence affects millions of women, especially those in the senior age bracket.  According to the Mayo Clinic, as many as 50% of women experience some form of leakage, and that number rises to around 75% in women over the age of 65.  The condition can cause anxiety and isolation for those who have it, but an Atlanta-based innovator is leading efforts to relieve their discomfort, and participants in the efforts she’s overseen are already reporting successes.  The company’s overall goal is to put urinary continence management more squarely in the hands of those experiencing it. We’re on a mission to give women effective, affordable, appealing alternatives to incontinence pads and surgery … to give consumers the ability to take care of these things for themselves up to a certain point,” said Melody Roberts, CEO and co-founder of Liv Labs.  A significant part of that goal lies in the success of a device the company is developing: the Pippa Pessary. Read more.

Source: Hastings Tribune, June 5, 2024

To Pee Or Not to Pee? That Is a Question for the Bladder — and the Brain

You’re driving somewhere, eyes on the road, when you start to feel a tingling sensation in your lower abdomen. That extra-large Coke you drank an hour ago has made its way through your kidneys into your bladder. “Time to pull over,” you think, scanning for an exit ramp.  To most people, pulling into a highway rest stop is a profoundly mundane experience. But not to neuroscientist Rita Valentino, who has studied how the brain senses, interprets and acts on the bladder’s signals. She’s fascinated by the brain’s ability to take in sensations from the bladder, combine them with signals from outside of the body, like the sights and sounds of the road, then use that information to act — in this scenario, to find a safe, socially appropriate place to pee. “To me, it’s really an example of one of the beautiful things that the brain does,” she says. Read more.

Source: Knowable Magazine, May 29, 2024

NorthShore Care Supply Announces Referral Program to Benefit Veterans With Disabilities

NorthShore Care Supply, the leading brand of adult diapers and absorbent products for heavy incontinence, is proud to announce its referral program in partnership with DAV (Disabled American Veterans).  This program allows existing customers to refer others to NorthShore, granting them exclusive discounts and raising money for DAV. With prices rising everywhere from the gas pump to the grocery store, people are looking for ways to save. The referral rewards program offers new customers a $10 discount on their first purchase and gives the existing customer a $10 discount off their future purchase of $100. Read more.

Source: Newswire, May 28, 2024

women friends

FDA Clears Yōni.Fit Device for Women With Stress Urinary Incontinence

The Food and Drug Administration (FDA) has cleared Yōni.Fit® Bladder Support for the temporary management of urine leakage caused by stress urinary incontinence (SUI) in women 18 years of age and older. Yōni.Fit is a self-administered, intravaginal insert that manages urinary incontinence without interfering with voluntary urination. The prescription device can be used during a specific activity or for up to 12 hours to control symptoms. Read more.

Source: Renal & Urology News, May 22, 2024

business buildings

Coloplast Expands Its Luja™ Portfolio with Next Generation Catheter for Women

The female intermittent catheter enables complete bladder emptying in one free flow, aiming to reduce the risk of urinary tract infections.  Following the successful launch of Luja with Micro-hole Zone Technology, a next generation intermittent catheter for men, Coloplast is now launching Luja for women.  “So far, we have received great feedback on Luja for men in our product evaluations. Nearly all healthcare professionals would recommend the male catheter to their patients, and seven out of ten users feel confident that it empties their bladder completely without needing to reposition the catheter4,” says Nicolai Buhl, Executive Vice President of Innovation. Read more.

Source: Globe Newswire, May 14, 2024

GRAMINEX®, L.L.C. Final Publication of a Peer Reviewed Clinical Trial with Graminex® Flower Pollen Extract Focusing on Women’s Urinary Incontinence in Current Urology

Graminex®, L.L.C. is pleased to announce publication of a peer reviewed clinical study with Graminex® Flower Pollen Extract for women’s urinary incontinence and urinary health in Current Urology. The study was conducted as a randomized, double-blind, placebo-controlled study to investigate the effectiveness of Graminex® Flower Pollen Extracts in 114 healthy women with urinary incontinence.  Read more.

Source: Business Wire, May 13, 2024